Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children

NCT01291381 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis
Effects of Immunotherapy

Interventions

DRUG: Dermatophagoides pteronyssinus
DRUG: Pharmacotherapy

Sponsor

Beijing Tongren Hospital